Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study details economic impact of RSV infections in young children​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV studies identify risk factors in older adults, household transmission routes​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study shows nirsevimab provides significant protection against RSV​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Reports describe good maternal RSV vaccine, drug uptake in their first season​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV vaccine prompts robust immune response in older recipients over 2 seasons​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity climbs, with more deaths in kids​
Load More
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Medical societies recommend RSV vaccines for older or immune-compromised adults​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Up to 56,000 people died from COVID-19 or RSV last year​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Rapid RSV tests linked to less antibiotic prescribing in kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Up to 56,000 people died from COVID-19 or RSV last year​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity still high, with 8 more pediatric deaths​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
CDC reports 6 more child deaths from flu, as virus levels stay moderate to high​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study ties adult RSV hospitalization to a higher risk of heart and lung problems in next 6 months​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women​